Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2011
06/01/2011CN102083826A Inhibitors of phosphatidylinositol 3-kinase
06/01/2011CN102083821A Hepatitis c virus inhibitors
06/01/2011CN102083820A Pyrrolidin-3-ylmethyl-amine as orexin antagonists
06/01/2011CN102083819A Novel phenylpyrazinones as kinase inhibitors
06/01/2011CN102083817A Compounds and compositions as ITPKB inhibitors
06/01/2011CN102083814A Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
06/01/2011CN102083813A Piperidinyl gpcr agonists
06/01/2011CN102083812A Muscarinic receptor agonits useful in the treatment of pain, alzheimer's disease and schizophrenia
06/01/2011CN102083811A 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors
06/01/2011CN102083810A Activator for peroxisome proliferator-activated receptor
06/01/2011CN102083809A Immunosuppressor based on the interruption of TCR-Nck interaction
06/01/2011CN102083807A Therapeutic compounds
06/01/2011CN102083806A 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
06/01/2011CN102083805A 4,5-dihydro-oxazol-2-yl derivatives
06/01/2011CN102083804A 5-phenyl-isoxazole-3-carboxamides modulating HSP90 with antitumoral activities
06/01/2011CN102083803A Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
06/01/2011CN102083801A Quinazoline derivatives and methods of treatment
06/01/2011CN102083800A Heteroaryl compounds and uses thereof
06/01/2011CN102083799A Benzimidazole derivatives used as FXR agonists
06/01/2011CN102083797A Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
06/01/2011CN102083794A Urea compounds as gamma secretase modulators
06/01/2011CN102083792A Compounds comprising a cyclobutoxy group
06/01/2011CN102083790A Spiro(5.5)undecane derivatives
06/01/2011CN102083787A Vinyl substituted fatty acids
06/01/2011CN102083783A Substituted biphenyl GPR40 modulators
06/01/2011CN102083780A Diglycidic ether derivative therapeutics and methods for their use
06/01/2011CN102083773A {F-19} -labeled L-glutamic acid and L-glutamine derivative (III), use thereof and method for obtaining them
06/01/2011CN102083772A Novel [F-18] -labelled L-glutamic acid- and L-glutamine derivatives (I), use thereof and method for their production
06/01/2011CN102083499A Combination therapy of a type II anti-CD20 antibody with a proteasome inhibitor
06/01/2011CN102083465A Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer
06/01/2011CN102083445A Nutritive compositions and methods of using same
06/01/2011CN102083444A Methods for preventing and treating neurodegenerative diseases
06/01/2011CN102083443A Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation
06/01/2011CN102083442A Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
06/01/2011CN102083441A Use of nifurtimox for treating giardiasis
06/01/2011CN102083440A Nifurtimox for treating diseases caused by trichomonadida
06/01/2011CN102083439A Methods for using TGF-beta receptor inhibitors or activin-like kinase (ALK) 5 inhibitors A-83-01 and SB-431542 to treat eye disease and wound healing conditions
06/01/2011CN102083438A Quenolines and related analogs as sirtuin modulators
06/01/2011CN102083437A Treatment of herpes virus related diseases
06/01/2011CN102083436A Anti-tumour compositions and methods
06/01/2011CN102083435A Telaprevir dosing regimen
06/01/2011CN102083434A Aqueous liquid containing gatifloxacin
06/01/2011CN102083433A Treatment of hepatitis c virus infections with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha-2A/2B and ribavirin
06/01/2011CN102083432A Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
06/01/2011CN102083431A Use of cyclolignans for the treatment of a hyperactive immune system
06/01/2011CN102083430A Anti-tumoural effects of cannabinoid combinations
06/01/2011CN102083429A Ido inhibitors
06/01/2011CN102083428A Methods of treatment employing prolonged continuous infusion of Belinostat
06/01/2011CN102083427A Inhibitors of carbonic anhydrase IX
06/01/2011CN102083426A Cannabinoids in combination with non -cannabinoid chemotherapeutic agents (e.g. serm or alkylating agents)
06/01/2011CN102083425A Methods of treating fungal infections
06/01/2011CN102083424A Methods and use of inducing apoptosis in cancer cells
06/01/2011CN102083422A Fenofibrate formulation with enhanced oral bioavailability
06/01/2011CN102083421A Lipid composition
06/01/2011CN102083419A Pharmaceutical composition containing surface-coated microparticles
06/01/2011CN102083418A Oral contraceptive dosage forms and methods of making such dosage forms
06/01/2011CN102083417A Novel dosage and formulation
06/01/2011CN102083416A Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
06/01/2011CN102083414A Composition comprising an antibiotic and a corticosteroid
06/01/2011CN102083413A Method and composition for treating ocular hypertension and glaucoma
06/01/2011CN102083408A Cosmetic compositions comprising exopolysaccharides derived from microbial mats, and use thereof
06/01/2011CN102080086A Human miR-133a antisense nucleic acid and application thereof
06/01/2011CN102080085A Human miR-193b antisense nucleotide and application thereof
06/01/2011CN102080084A Human miR-125a-5p antisense nucleotide and application thereof
06/01/2011CN102080083A Human miR-149 antisense nucleotide and application thereof
06/01/2011CN102080082A Human miR-129* antisensenucleic acid and applications thereof
06/01/2011CN102079795A Preparation of water-soluble crosslinked chitosan and application thereof
06/01/2011CN102079793A Method for preparing sinonovacula constricta lamarck polysaccharide with various biological activities
06/01/2011CN102079772A Pentacyclic triterpene-13,28-lactone compounds as well as preparation method and application thereof
06/01/2011CN102079769A Cyclopropyl pregnene compound and application thereof
06/01/2011CN102079765A 9-O-glucoside-berberine salt, and preparation method and application thereof
06/01/2011CN102079763A Dioxabicyclo-octane compound, preparation method and application thereof
06/01/2011CN102079761A Water-soluble S, S-heptaplatin derivative
06/01/2011CN102079759A 6-substituted quinazoline derivative, preparation method and application thereof
06/01/2011CN102079746A Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors
06/01/2011CN102079744A Deuterated achiral crizotinib and derivatives, preparation method and application thereof
06/01/2011CN102079743A Dipeptidyl peptidase inhibitors
06/01/2011CN102079739A Daidzein derivative, preparation method and application thereof
06/01/2011CN102079735A Terphenyl compound and preparation method thereof and application of compound as acetylcholinesterase inhibitor
06/01/2011CN102079729A Compounds with antiparasitic activity and medicaments containing them
06/01/2011CN102079726A Miazine compounds, intermediates of miazine compounds, preparation method of intermediates and miazine compounds as well as application of miazine compound
06/01/2011CN102079724A Ethylene sulfonyl chloride azole compounds with anti-microbial activity as well as preparation method and medical use thereof
06/01/2011CN102079717A Arginine salt compound of dibasic ester acids and preparation method and medicinal application thereof
06/01/2011CN102079715A Lysine salt compound of binary ester acid, preparation method and medicinal application
06/01/2011CN102079703A Method for preparing novel nonsteroidal anti-inflammatory drug and anti-inflammatory and analgesic effects thereof
06/01/2011CN102079700A Method for synthesizing novel tetracyclic diterpene compound from stevioside
06/01/2011CN102079699A New crystal form for sodium valproate and preparation method and usage thereof
06/01/2011CN102079692A Terphenyl compound and preparation method of terphenyl compound and application of terphenyl compound as alpha-glucosidase inhibitor
06/01/2011CN102078637A Sodium alginate/tamarind gum blended drug-loaded membrane as well as preparation method and application thereof
06/01/2011CN102078620A Pharmaceutical composition comprising a strontium salt, vitamine d and a cyclodextrine
06/01/2011CN102078619A Transdermal therapeutic preparation
06/01/2011CN102078616A Esomeprazole sodium bicarbonate composition
06/01/2011CN102078614A Method for inhibiting shortsightedness and application of adenylate cyclase inhibitor as medicament for inhibiting shortsightedness
06/01/2011CN102078612A Nasal in-situ gel containing mometasone furoate and H1 receptor antagonist
06/01/2011CN102078611A Partial external use composition containing povidone Iodine and cyclodextrin inclusion glucocorticoid
06/01/2011CN102078610A Application of combination of DCK (deoxycytidine kinase) analogue and CYP3A4 inhibitor
06/01/2011CN102078604A Meningococcus capsular polysaccharide polyvalent multivalent conjugate vaccine, preparation method and application thereof
06/01/2011CN102078600A Anti-cancer compound ganoderma composition, application thereof and pharmaceutical composition containing same
06/01/2011CN102078599A Compound trimebutine maleate preparation and preparation method thereof
06/01/2011CN102078598A Injection for preventing and treating porcine viral diseases and preparation method thereof
1 ... 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 ... 7860